Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial
about
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and managementClinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)De-escalating therapy in gastric aggressive lymphomaClinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseRole of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomasTreatment of gastric marginal zone lymphoma of MALT type.Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.Systematic review of the recent evidence for the efficacy and safety of chlorambucil in the treatment of B-cell malignancies.First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice.Effective management strategies for patients with marginal zone lymphoma.
P2860
Q26741090-C8A3430E-5660-4222-AAF8-5DEBE7812F64Q26771654-8B73ACB7-4DB3-4A84-A673-F93C0F2140A2Q27694672-BA61129F-9F85-41CB-B91C-0F3DFE840955Q33391725-7D4F2F7E-BF3F-4408-984C-ABE4D4ED5A4AQ36777008-E8B650DD-F119-468F-A746-4E4028C83BEAQ37578581-DA3361CB-957A-4060-B8D4-46D13E292B71Q37768456-E3C66C3E-9DAA-4FB2-B9FE-7E8B54B9E75CQ37944372-C1322FFE-352E-461F-9EF4-EAECD819CD5CQ38544142-6F3C5B6F-E2E3-4485-B051-A932D0168342Q38574045-7D3E77A4-B279-433E-96EF-42F8397B2620Q43045933-34037BAC-4DBB-4D36-B02C-2C57014EBF17Q43635791-AC5992CA-5189-4196-B831-F469508E18CBQ45150144-CF4CACA4-CE58-407B-8072-0AC073E3A226Q47278073-D5230615-8737-4EC5-8E27-25FAB378175F
P2860
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chlorambucil versus observatio ...... national randomised LY03 trial
@ast
Chlorambucil versus observatio ...... national randomised LY03 trial
@en
Chlorambucil versus observatio ...... national randomised LY03 trial
@nl
type
label
Chlorambucil versus observatio ...... national randomised LY03 trial
@ast
Chlorambucil versus observatio ...... national randomised LY03 trial
@en
Chlorambucil versus observatio ...... national randomised LY03 trial
@nl
prefLabel
Chlorambucil versus observatio ...... national randomised LY03 trial
@ast
Chlorambucil versus observatio ...... national randomised LY03 trial
@en
Chlorambucil versus observatio ...... national randomised LY03 trial
@nl
P2093
P2860
P50
P1476
Chlorambucil versus observatio ...... national randomised LY03 trial
@en
P2093
Achille Ambrosetti
Andres J M Ferreri
Barry W Hancock
Carlo Capella
Catherine Traulle
Cathy Burton
Christian Gisselbrecht
David Linch
Emanuele Zucca
Franco Cavalli
P2860
P304
P356
10.1111/J.1365-2141.2008.07486.X
P407
P577
2008-11-22T00:00:00Z